{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T05:04:46Z","timestamp":1773983086174,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ebiomedicine.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.ebiom.2015.08.017","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T12:21:50Z","timestamp":1439036510000},"page":"1494-1499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster"],"prefix":"10.1016","volume":"2","author":[{"given":"Alies","family":"van Lier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lugn\u00e9r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Opstelten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Jochemsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacco","family":"Wallinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Schellevis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel","family":"van Boven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2015.08.017_bb0080","series-title":"Infectious Diseases of Humans: Dynamics and Control","author":"Anderson","year":"1991"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0145","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/hv.23334","article-title":"Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?","volume":"9","author":"Bilcke","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1741-7015-7-26","article-title":"Varicella vaccination in Europe \u2014 taking the practical approach","volume":"7","author":"Bonanni","year":"2009","journal-title":"BMC Med."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S0950268800004714","article-title":"Modelling the impact of immunization on the epidemiology of varicella zoster virus","volume":"125","author":"Brisson","year":"2000","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0040","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0090","series-title":"Varicella-Zoster Virus: Virology and Clinical Management","first-page":"317","article-title":"Varicella and Herpes Zoster in Pregnancy and the Newborn","author":"Enders","year":"2000"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0030","series-title":"ECDC Guidance: Varicella Vaccination in the European Union","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2015"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0015","series-title":"Immunisation schedules Varicella","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2014"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0065","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1467-842X.2005.tb00248.x","article-title":"Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia","volume":"29","author":"Gidding","year":"2005","journal-title":"Aust. N. Z. J. Public Health"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0150","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2012.05.050","article-title":"Review of the United States universal varicella vaccination program: herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data","volume":"31","author":"Goldman","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0115","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/aje\/kws370","article-title":"Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data","volume":"177","author":"Guzzetta","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0125","series-title":"[Guidelines for pharmacoeconomic research]","article-title":"Handleiding voor kostenonderzoek \u2014 Methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg; geactualiseerde versie 2010","author":"Hakkaart-van Roijen","year":"2011"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0085","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0035","first-page":"9","article-title":"The nature of herpes zoster: a long-term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0130","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1016\/j.vaccine.2010.02.021","article-title":"on behalf of the National Immunisation Programme Review Committee of the Health Council of the Netherlands. Criteria for inclusion of vaccinations in public programmes","volume":"28","author":"Houweling","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1017\/S0950268809990768","article-title":"Modelling the impact of varicella vaccination on varicella and zoster","volume":"138","author":"Karhunen","year":"2010","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0155","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.41.20926","article-title":"Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012","volume":"19","author":"Kelly","year":"2014","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0025","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0110","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0050","doi-asserted-by":"crossref","first-page":"e66485","DOI":"10.1371\/journal.pone.0066485","article-title":"Herpes zoster risk reduction through exposure to chickenpox patients: a systematic multidisciplinary review","volume":"8","author":"Ogunjimi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0075","series-title":"Varicella-Zoster Virus: Virology and Clinical Management","first-page":"246","article-title":"Clinical Manifestations of Herpes Zoster","author":"Oxman","year":"2000"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0095","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1586\/14760584.7.6.753","article-title":"Cost-effectiveness of varicella vaccination programs: an update of the literature","volume":"7","author":"Rozenbaum","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1006\/bulm.1999.0126","article-title":"Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles","volume":"61","author":"Schuette","year":"1999","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0105","series-title":"National Information Network Primary Care (LINH): Facts and Figures on Primary Care in the Netherlands","author":"Stirbu-Wagner","year":"2011"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0135","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0045","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0140-6736(02)09837-9","article-title":"Contacts with varicella or with children and protection against herpes zoster in adults: a case\u2013control study","volume":"360","author":"Thomas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0140","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.4161\/hv.25228","article-title":"Economic evaluation of varicella vaccination: results of a systematic review","volume":"9","author":"Unim","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ebiom.2015.08.017_bb0120","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.vaccine.2011.11.026","article-title":"The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom","volume":"30","author":"van Hoek","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0100","doi-asserted-by":"crossref","first-page":"5127","DOI":"10.1016\/j.vaccine.2013.08.029","article-title":"Varicella zoster virus infection occurs at a relatively young age in The Netherlands","volume":"31","author":"van Lier","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2015.08.017_bb0020","first-page":"265","article-title":"Varicella and Herpes Zoster Vaccines: WHO Position Paper, June 2014","volume":"89","year":"2014","journal-title":"Wkly Epidemiol. Rec."}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415301092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396415301092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T05:50:31Z","timestamp":1537422631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396415301092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2352396415301092"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.08.017","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2015.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}